Reported Reactions

Devices › Prosthesis, breast, noninflatable, internal, silicone gel-filled

Device brand name · Prosthesis breast noninflatable internal silicone gel-filled

CUI Textured Silicone Gel Filled Breast Implant: medical device reports filed with FDA

192 reports name it, 2016–2026. Manufacturer given most often on reports: Allergan Costa Rica. Product code FTR.

192
device reports naming the brand
0% of all MAUDE reports · about 19 a year
46
reports, 12 months to August 2026
36 in the 12 months before
0%
classified as malfunction
1.6% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 192 reports that name the brand "CUI Textured Silicone Gel Filled Breast Implant" (prosthesis breast noninflatable internal silicone gel-filled), received between August 2016 and August 2026; the manufacturer given most often on reports is Allergan Costa Rica. Spellings of one product vary from report to report.

46 reports arrived in the 12 months to August 2026, up 28% from 36 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all prosthesis, breast, noninflatable, internal, silicone gel-filled reports (product code FTR) death is recorded in 0.1% and malfunction in 1.6%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are material rupture (56.3%), device appears to trigger rejection (22.4%) and migration (6.3%). The patient problems coded most often are failure of implant, capsular contracture and seroma. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

048Sep 2021: 0Oct 2021: 0Nov 2021: 1Dec 2021: 22022Jan 2022: 0Feb 2022: 0Mar 2022: 1Apr 2022: 1May 2022: 1Jun 2022: 1Jul 2022: 0Aug 2022: 2Sep 2022: 0Oct 2022: 1Nov 2022: 0Dec 2022: 12023Jan 2023: 0Feb 2023: 2Mar 2023: 1Apr 2023: 6May 2023: 2Jun 2023: 4Jul 2023: 3Aug 2023: 2Sep 2023: 2Oct 2023: 3Nov 2023: 4Dec 2023: 22024Jan 2024: 2Feb 2024: 2Mar 2024: 3Apr 2024: 7May 2024: 6Jun 2024: 1Jul 2024: 8Aug 2024: 3Sep 2024: 3Oct 2024: 3Nov 2024: 0Dec 2024: 42025Jan 2025: 5Feb 2025: 1Mar 2025: 4Apr 2025: 0May 2025: 5Jun 2025: 1Jul 2025: 8Aug 2025: 2Sep 2025: 1Oct 2025: 7Nov 2025: 6Dec 2025: 22026Jan 2026: 4Feb 2026: 3Mar 2026: 2Apr 2026: 3May 2026: 2Jun 2026: 8Jul 2026: 4Aug 2026: 4

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

021422016: 320162019: 920192020: 820202021: 1920212022: 820222023: 3120232024: 4220242025: 4220252026: 302026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%192
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%192
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 231,877 reports carrying product code FTR. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Material rupture10856.3%42.7%
Device appears to trigger rejection4322.4%21.6%
Migrationthe device moved from where it was placed126.3%2.4%
Patient-device incompatibilitythe device did not suit the patient42.1%6.6%
Gel leak21%1.9%
Fluid/blood leak10.5%0.2%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant7639.6%
Capsular contracturescar tissue tightening around an implant4624%
Seromaa collection of fluid under the skin3417.7%
Lymphomaa cancer of the lymphatic system2312%
Breast implant associated anaplastic large cell lymphoma (bia alcl)157.8%
Swollen lymph nodes/glands94.7%
Granuloma84.2%
Breast mass10.5%
Fluid discharge10.5%
Foreign body reaction10.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCUI Textured Silicone Gel Filled Breast ImplantProduct code FTRAll MAUDE reports
Reports192231,87726,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports019
Classified as injury100%97.7%36.2%
Classified as malfunction0%1.6%62.3%
Filed by the manufacturer100%95%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code FTR

BrandReportsLatest 12 monthsClassified as death
MENTOR MemoryGel Breast Implant57,7717,7080%
Inspira Smooth Silicone Gel Filled Breast Implant35,6346,7820%
Inspira Textured Silicone Gel Filled Breast Implant24,7952,7660%
Style 410 Cohesive Silicone Gel Filled Breast Implant15,2871,8410.1%
Style 15 Silicone Gel Filled Breast Implant9,5671,5290.1%
Style 20 Silicone Gel Filled Breast Implant6,3689810.1%
Sientra Silicone Gel Breast Implants6,0141,6820%
Style 115 Silicone Gel Filled Breast Implant5,7105460%
Unknown Gel Implants5,3377030%
UNK Gel Breast Implant5,3027820.4%
MENTOR MemoryGel Xtra Breast Implant4,9101,3870%
Inspira Smooth Cohesive Silicone Gel Filled Breast Implant4,6361,0760%
Sientra Opus Silicone Gel Breast Implant4,61300%
Style 110 Silicone Gel Filled Breast Implant3,3642790%
Style 10 Silicone Gel Filled Breast Implant3,3534790.1%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CUI Textured Silicone Gel Filled Breast Implant reports

How many FDA reports name CUI Textured Silicone Gel Filled Breast Implant?

192 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 46 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

material rupture (56.3%), device appears to trigger rejection (22.4%), migration (6.3%), patient-device incompatibility (2.1%) and gel leak (1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CUI Textured Silicone Gel Filled Breast Implant was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.